Search
SEEBRI BREEZHALER 50 µg, Gélule avec inhalateur
Details
| --- | Description |
|---|---|
| Pack | Inhalateur et 30 gélules |
| Strength (Dosage) | 50 µg |
| Laboratory | NOVARTIS PHARMA MAROC |
| Ingredients | Glycopyrronium |
| Therapeutic class | Parasympatholytique |
| ATC code | R03BB06 |
| PPH | $32.30 |
| PPV | $48.90 |
| Refundable | Yes |
| Refund base | $48.90 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Seebri Breezhaler est indiqué chez l’adulte en traitement bronchodilatateur continu pour soulager les symptômes de la broncho-pneumopathie chronique obstructive (BPCO). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem